News on the Division of Lung Diseases

Graphical abstract of findings presenting an in vitro human model that simulates the initial apical infection of alveolar epithelium with SARS-CoV-2 by using induced pluripotent stem cell-derived AT2s that have been adapted to air-liquid interface culture.
Credit: Jessie Huang et al, Cell Stem Cell.
|
NHLBI in the Press
A team of NHLBI-funded researchers has discovered a biological pathway that triggers deadly levels of lung inflammation when activated by SARS-CoV-2, the coronavirus that causes COVID-19.